Skip to main content
Black Friday Sale - Get 40% off Vantage
Published loading...Updated

Cornell launches clinical trial of once-weekly GLP-1 therapy for feline weight management

Summary by dvm360.com
Cornell University is enrolling client-owned cats in an 11-week trial of AKS-562c, a once-weekly GLP-1 Fc-fusion candidate designed to reduce appetite and produce clinically meaningful weight loss while closely monitoring safety and tolerability.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

dvm360.com broke the news in on Tuesday, November 25, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal